GlobeNewswire 2025-10-03 Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
GlobeNewswire 2025-10-02 AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meetin...
GlobeNewswire 2025-09-30 Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kama...
GlobeNewswire 2025-09-26 Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old...
GlobeNewswire 2025-09-25 BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
GlobeNewswire 2025-09-24 Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
GlobeNewswire 2025-09-24 BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders
GlobeNewswire 2025-09-22 First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson...
GlobeNewswire 2025-09-22 First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational c...
GlobeNewswire 2025-09-22 Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU...
GlobeNewswire 2025-09-22 Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP...
GlobeNewswire 2025-09-19 Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
GlobeNewswire 2025-09-19 Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
GlobeNewswire 2025-09-17 Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agon...
GlobeNewswire 2025-09-17 AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Mult...
GlobeNewswire 2025-09-17 Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia...
GlobeNewswire 2025-09-16 Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV
GlobeNewswire 2025-09-16 Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
GlobeNewswire 2025-09-16 Indicium Receives Investment from Databricks Ventures
TeleTrader 2025-09-11 Europe closes higher after ECB decision
GlobeNewswire 2025-09-10 Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mo...
GlobeNewswire 2025-09-09 Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Impr...
GlobeNewswire 2025-09-08 DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors 
GlobeNewswire 2025-09-08 Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antib...
GlobeNewswire 2025-09-08 CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer